DNA Topoisomerase IV (EC 5.99.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Coagulation Factor VII (Proconvertin or Serum Prothrombin Conversion Accelerator or SPCA or Eptacog Alfa or F7 or EC 3.4.21.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Maple Syrup Urine Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
DNA Topoisomerase II (EC 5.99.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players